CEACAM1 homophilic interactions between TILs and melanoma cells appear to dampen in vivo TIL functions, limiting the efficacy of TIL adoptive cell transfer therapy in melanoma patients [46]. This evidence concerns the gene CEACAM1 and melanoma.